特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
962943

世界の白血病治療薬市場規模調査:タイプ別、用途別、地域別予測(2019年~2025年)

Global Leukemia Therapeutics Market Size Study, by type, by application and Regional Forecasts - 2019 To 2025

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
世界の白血病治療薬市場規模調査:タイプ別、用途別、地域別予測(2019年~2025年)
出版日: 2020年10月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の白血病治療薬の市場規模は2019年に約125億米ドルとなりました。同市場は、2020年から2027年の予測期間にわたって6.0%を超えるCAGRで成長すると予想されています。

白血病関連の治療法は、血液成分や骨髄を含む造血組織の血液癌を標的としています。この症状は、骨髄が損傷したリンパ球を産生し、抗体の産生が機能不全になるもので、感染と闘う能力に影響を与えます。高齢者人口の増加と、白血病の早期診断と治療に関連したアンメットニーズの高さは、市場を牽引する重要な要因です。

2018年にWHOが発表したレポートによると、世界的に白血病は、男性の0.0148%、女性の0.009%と、男性の血液癌の罹患率が高くなっています。また、創薬の革新、バイオテクノロジー企業の数の増加、および研究開発部門への投資の増加も、予測期間におけるこの市場の成長を促進すると予測されています。さらに、癌の認識を促進するためのさまざまな政府の取り組みは、予測期間の2020年~2027年に世界の白血病治療薬市場の成長を促進するでしょう。

認可外の処方は治療をより利用しやすくし、世界の白血病治療薬市場の成長につながります。さらに、市場のプレーヤーが限られていることは、世界の白血病治療薬市場の成長のための豊富な機会となるとみられています。しかし、研究開発に多額の投資が必要なため、市場は抑制されているようです。

当レポートでは、世界の白血病治療薬市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の白血病治療薬市場の定義と範囲

第3章 世界の白血病治療薬市場力学

  • 白血病治療薬市場の影響分析(2020-2027)

第4章 世界の白血病治療薬市場産業分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界の白血病治療薬市場、タイプ別

  • 市場スナップショット
  • 世界の白血病治療薬市場、パフォーマンス-潜在的な分析:タイプ別
  • 世界の白血病治療薬市場の見積と予測:2020-2027年(百万米ドル):タイプ別
  • 白血病治療薬市場、サブセグメント分析
    • 急性骨髄性白血病
    • 慢性骨髄性白血病
    • 急性リンパ芽球性白血病
    • 慢性リンパ性白血病

第6章 世界の白血病治療薬市場、用途別

  • 市場スナップショット
  • 世界の白血病治療薬市場、パフォーマンス-潜在的な分析:用途別
  • 世界の白血病治療薬市場の見積と予測:2020-2027年(百万米ドル):用途別
  • 白血病治療薬市場、サブセグメント分析
    • 化学療法
    • 放射線治療
    • 標的療法
    • 生物学的療法
    • 幹細胞移植

第7章 世界の白血病治療薬市場、地域分析

  • 地域市場のスナップショット
  • 北米白血病治療薬市場
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • 中南米スナップショット
    • ブラジル
    • メキシコ
  • その他

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
  • Biogen
  • GSK
  • Novartis AG
  • Pfizer
  • Roche
  • Takeda Oncology
  • Teva Pharmaceutical
  • Celgene
  • 第一三共株式会社
  • エーザイ株式会社

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Leukemia Therapeutic Market , report scope
  • TABLE 2. Global Leukemia Therapeutic Market estimates & forecasts by region 2020-2027(USD Million)
  • TABLE 3. Global Leukemia Therapeutic Market estimates & forecasts by type 2020-2027(USD Million)
  • TABLE 4. Global Leukemia Therapeutic Market estimates & forecasts by route 2020-2027(USD Million)
  • TABLE 5. Global Leukemia Therapeutic Market estimates & forecasts by facility of use 2020-2027(USD Million)
  • TABLE 6. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 7. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 8. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 9. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 10. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 11. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 12. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 13. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 14. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 15. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 16. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 17. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 18. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 19. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 20. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 21. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
  • TABLE 22. U.S. Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 23. U.S. Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 24. U.S. Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 25. Canada Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 26. Canada Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 27. Canada Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 28. UK Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 29. UK Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 30. UK Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 31. Germany Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 32. Germany Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 33. Germany Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 34. France Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 35. France Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 36. France Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 37. Spain Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 38. Spain Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 39. Spain Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 40. Italy Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 41. Italy Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 42. Italy Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 43. ROE Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 44. ROE Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 45. ROE Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 46. China Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 47. China Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 48. China Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 49. India Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 50. India Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 51. India Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 52. Japan Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 53. Japan Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 54. Japan Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 55. Australia Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 56. Australia Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 57. Australia Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 58. South Korea Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 59. South Korea Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 60. South Korea Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 61. ROPAC Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 62. ROPAC Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 63. ROPAC Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 64. Brazil Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 65. Brazil Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 66. Brazil Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 67. Mexico Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 68. Mexico Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 69. Mexico Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 70. ROLA Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 71. ROLA Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 72. ROLA Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 73. ROW Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
  • TABLE 74. ROW Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 75. ROW Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
  • TABLE 76. List of secondary End-Users, used in the study of global Leukemia Therapeutic Market
  • TABLE 77. List of primary End-Users, used in the study of global Leukemia Therapeutic Market
  • TABLE 78. Years considered for the study
  • TABLE 79. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Leukemia Therapeutic Market , research methodology
  • FIG 2. Global Leukemia Therapeutic Market , market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Leukemia Therapeutic Market , key trends 2019
  • FIG 5. Global Leukemia Therapeutic Market , growth prospects 2020-2025
  • FIG 6. Global Leukemia Therapeutic Market , porters 5 force Model
  • FIG 7. Global Leukemia Therapeutic Market , pest analysis
  • FIG 8. Global Leukemia Therapeutic Market , value chain analysis
  • FIG 9. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 10. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 11. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 12. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 13. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 14. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 15. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 16. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
  • FIG 17. Global Leukemia Therapeutic Market , regional snapshot 2019 & 2025
  • FIG 18. North America Leukemia Therapeutic Market 2020 & 2027 (USD Million)
  • FIG 19. Europe Leukemia Therapeutic Market 2020 & 2027 (USD Million)
  • FIG 20. Asia-Pacific Leukemia Therapeutic Market 2020 & 2027 (USD Million)
  • FIG 21. Latin America Leukemia Therapeutic Market 2020 & 2027 (USD Million)
  • FIG 22. Global Leukemia Therapeutic Market , company market share analysis (2019)
目次

Title:
Global Leukemia Therapeutics Market Size Study, by type (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia), by application (Chemotherapy, Radiation Therapy, Targeted Therapy, Biological Therapy, Stem Cell Transplant) and Regional Forecasts - 2019 To 2025.

Global Leukemia Therapeutics Market is valued approximately at USD 12500 Million in 2019 and is anticipated to grow with a CAGR of more than 6.0% over the forecast period 2020-2027. Leukemia associated therapeutics targets haematological cancer of blood-forming tissues, inclusive of the blood components and bone -marrow. This condition occurs when bone marrow produces damaged lymphocytes which causes dysfunctional in production of antibodies thus affecting their ability to fight against infection. Rise in geriatric population base and high unmet needs in context with early diagnosis and treatment of Leukemia are the key factors driving the market. In accordance with the report published by WHO in 2018, globally Leukemia is more prevalent blood cancer in males, 0.0148% men, and 0.009% women worldwide. Also, innovation in drug discovery, rise in volume of biotechnology firms, and increasing investments in the R&D sector are also foreseen to fuel the growth of this market in forecasted period. Furthermore, various government initiatives to promote cancer awareness will fuel the growth of the gloabal Leukemia therapeutic market during forecasted period 2020-2027 Off label prescribing will make treatment more accessible thus leading to growth of the global Leukemia therapeutics market. In addition, presence of limited number of players in market represents a lucrative opportunity for growth of the global Leukemia therapeutic market. However , heavy investment required in research and development seems to restrain the market.

The regional analysis of Leukemia Therapeutic Market is considered for the key regions such as North America, Europe, APAC, MEA, Latin America and rest of the world . North America holds the major market share for Leukemia therapeutics market throughout the coming years followed by Europe owing to the increase in cases of Leukemia and large availability of treatment options. Whereas, the Asia Pacific is foreseen to exhibit highest growth rate / CAGR over the forecast period 2019-2025 due to rising incidence of cancer. China and India are expected to be the fastest growing Leukemia markets in Asia region. Some of the key driving forces for the Leukemia therapeutic market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.

Major market player included in this report are:

Biogen

GSK

Novartis AG

Pfizer

Roche

Takeda Oncology

Teva Pharmaceutical

Celgene

Daiichi Sankyo

EISAI Co., Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Acute Myeloid Leukemia

Chronic Myeloid Leukemia

Acute Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

By Application:

Chemotherapy

Radiation Therapy

Targeted Therapy

Biological Therapy

Stem Cell Transplant

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year -2019

Base year - 2019

Forecast period - 2019-2025

Target Audience of the Smart Learning Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2027(USD Million)
    • 1.2.1. Leukemia Therapeutic Market , by Region, 2020-2027(USD Million)
    • 1.2.2. Leukemia Therapeutic Market , by type, 2020-2027(USD Million)
    • 1.2.3. Leukemia Therapeutic Market , by application , 2020-2027(USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Leukemia Therapeutic Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Leukemia Therapeutic Market Dynamics

  • 3.1. Leukemia Therapeutic Market Impact Analysis (2020-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Leukemia Therapeutic Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2020-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Leukemia Therapeutic Market , by type

  • 5.1. Market Snapshot
  • 5.2. Global Leukemia Therapeutic Market by type, Performance - Potential Analysis
  • 5.3. Global Leukemia Therapeutic Market Estimates & Forecasts by type 2020-2027(USD Million)
  • 5.4. Leukemia Therapeutic Market, Sub Segment Analysis
    • 5.4.1. Acute Myeloid Leukaemia
    • 5.4.2. Chronic Myeloid Leukaemia
    • 5.4.3. Acute Lymphoblastic Leukaemia
    • 5.4.4. Chronic Lymphocytic Leukaemia

Chapter 6. Global Leukemia Therapeutic Market , by application

  • 6.1. Market Snapshot
  • 6.2. Global Leukemia Therapeutic Market by application - Potential Analysis
  • 6.3. Global Leukemia Therapeutic Market Estimates & Forecasts by route 2020-2027(USD Million)
  • 6.4. Leukemia Therapeutic Market , Sub Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Radiation Therapy
    • 6.4.3. Targeted Therapy
    • 6.4.4. Biological Therapy
    • 6.4.5. Stem Cell Transplant

Chapter 7. Global Leukemia Therapeutic Market , Regional Analysis

  • 7.1. Leukemia Therapeutic Market , Regional Market Snapshot
  • 7.2. North America Leukemia Therapeutic Market
    • 7.2.1. U.S. Leukemia Therapeutic Market
      • 7.2.1.1. Application breakdown estimates & forecasts, 2020-2027
      • 7.2.1.2. Type breakdown estimates & forecasts, 2020-2027
    • 7.2.2. 2020-2027Canada Leukemia Therapeutic Market
  • 7.3. Europe Leukemia Therapeutic Market Snapshot
    • 7.3.1. U.K. Leukemia Therapeutic Market
    • 7.3.2. Germany Leukemia Therapeutic Market
    • 7.3.3. France Leukemia Therapeutic Market
    • 7.3.4. Spain Leukemia Therapeutic Market
    • 7.3.5. Italy Leukemia Therapeutic Market
    • 7.3.6. Rest of Europe Leukemia Therapeutic Market
  • 7.4. Asia-Pacific Leukemia Therapeutic Market Snapshot
    • 7.4.1. China Leukemia Therapeutic Market
    • 7.4.2. India Leukemia Therapeutic Market
    • 7.4.3. Japan Leukemia Therapeutic Market
    • 7.4.4. Australia Leukemia Therapeutic Market
    • 7.4.5. South Korea Leukemia Therapeutic Market
    • 7.4.6. Rest of Asia Pacific Leukemia Therapeutic Market
  • 7.5. Latin America Leukemia Therapeutic Market Snapshot
    • 7.5.1. Brazil Leukemia Therapeutic Market
    • 7.5.2. Mexico Leukemia Therapeutic Market
  • 7.6. Rest of The World Leukemia Therapeutic Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
  • 8.3. Biogen
  • 8.4. GSK
  • 8.5. Novartis AG
  • 8.6. Pfizer
  • 8.7. Roche
  • 8.8. Takeda Oncology
  • 8.9. Teva Pharmaceutical
  • 8.10. Celgene
  • 8.11. Daiichi Sankyo
  • 8.12. EISAI Co., Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.